This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Biogen Idec(BIIB - Get Report) upgraded at Credit Suisse from Neutral to Outperform. $126 price target. Estimates also boosted, given higher expectations for BG12.
Boston Scientific(BSX - Get Report) rated new Buy at Stifel Nicolaus. $9 price target. Earnings growth could soon begin to accelerate.
F5 Networks(FFIV - Get Report) upgraded at Barclays from Equal Weight to Overweight. $125 price target. Estimates also increased through 2012. F5's revenue pipeline and market are healthy.
Forest Oil(FST) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $34 price target. Stock has pulled back to an attractive level.
Hexcel(HXL - Get Report) upgraded at Keybanc from Hold to Buy. $28 price target. Company is leveraged to higher commercial aerospace demand.
Polo Ralph Lauren(RL - Get Report) rated new Outperform at Wells. Recent investments should help future growth.
Synovus Financial(SNV) downgraded at Wunderlich from Buy to Hold. $2.50 price target. Company still faces significant earnings headwinds.
Susquehanna(SUSQ) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. Valuation call, based on a $10 price target.
Western Refining(WNR) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $24 price target. Company is leveraged to a wider Brent-WTI spread.
VCA Antech(WOOF) rated new Outperform at Barrington Research. $28 price target. Company generates significant free cash flow.
End of report.